Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Ansquer

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|July 16, 2009
Current status and perspectives in peptide receptor radiation therapyCatherine Ansquer, Françoise Kraeber-Bodéré, Jean François Chatal
The Journal of Urology|December 20, 2011
Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penisIsabelle Souillac, Jérôme Rigaud, Catherine Ansquer, et al.
Clinical Nuclear Medicine|July 16, 2019
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic PheochromocytomaAlexandre Lugat, Delphine Drui, Eric Mirallié, et al.
Clinical Nuclear Medicine|January 3, 2018
Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome: Hypoglycemia Treated by 90Y RadioembolizationClement Bailly, Myriam Bichali Alroumani, Frederic Douane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2021
Female Authors in Nuclear Medicine Journals: A Survey from 2014 to 2020Charline Lasnon, Gilles Girault, Rachida Lebtahi, et al.
Endocrine|March 16, 2019
Novel PET tracers: added value for endocrine disordersSébastien Bergeret, Judith Charbit, Catherine Ansquer, et al.
Joint Bone Spine|October 12, 2016
Contribution of 18-FDG PET/CT to brown tumor detection in a patient with primary hyperparathyroidismMélanie Gahier Penhoat, Delphine Drui, Catherine Ansquer, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative <sup>18</sup>F-FDG PET/CT: Don't Forget the Thyroid!Alexandre Lugat, Pauline Hulo, Catherine Ansquer, et al.
Nuclear Medicine Communications|April 17, 2013
Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experienceAlina Lintia-Gaultier, Christophe Perret, Catherine Ansquer, et al.
Joint Bone Spine|October 4, 2015
Sodium (18)F-sodium fluoride PET failed to predict responses to TNFα antagonist therapy in 31 patients with possible spondyloarthritis not meeting ASAS criteriaChristelle Darrieutort-Laffite, Catherine Ansquer, Yves Maugars, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|July 16, 2009
Current status and perspectives in peptide receptor radiation therapyCatherine Ansquer, Françoise Kraeber-Bodéré, Jean François Chatal
The Journal of Urology|December 20, 2011
Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penisIsabelle Souillac, Jérôme Rigaud, Catherine Ansquer, et al.
Clinical Nuclear Medicine|July 16, 2019
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic PheochromocytomaAlexandre Lugat, Delphine Drui, Eric Mirallié, et al.
Clinical Nuclear Medicine|January 3, 2018
Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome: Hypoglycemia Treated by 90Y RadioembolizationClement Bailly, Myriam Bichali Alroumani, Frederic Douane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2021
Female Authors in Nuclear Medicine Journals: A Survey from 2014 to 2020Charline Lasnon, Gilles Girault, Rachida Lebtahi, et al.
Endocrine|March 16, 2019
Novel PET tracers: added value for endocrine disordersSébastien Bergeret, Judith Charbit, Catherine Ansquer, et al.
Joint Bone Spine|October 12, 2016
Contribution of 18-FDG PET/CT to brown tumor detection in a patient with primary hyperparathyroidismMélanie Gahier Penhoat, Delphine Drui, Catherine Ansquer, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative <sup>18</sup>F-FDG PET/CT: Don't Forget the Thyroid!Alexandre Lugat, Pauline Hulo, Catherine Ansquer, et al.
Nuclear Medicine Communications|April 17, 2013
Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experienceAlina Lintia-Gaultier, Christophe Perret, Catherine Ansquer, et al.
Joint Bone Spine|October 4, 2015
Sodium (18)F-sodium fluoride PET failed to predict responses to TNFα antagonist therapy in 31 patients with possible spondyloarthritis not meeting ASAS criteriaChristelle Darrieutort-Laffite, Catherine Ansquer, Yves Maugars, et al.
Pageof 5